Cell type-specific Nrf2 expression in multiple sclerosis lesions

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Oxidative injury significantly contributes to demyelination and neurodegeneration in multiple sclerosis (MS).
• Endogenous antioxidant defenses in MS lesions are often insufficient to prevent damage.
• Therapies for MS aim to enhance antioxidant defenses by targeting the Nrf2 pathway.

Purpose of the Study:

• To investigate the expression and activity of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) in active multiple sclerosis (MS) lesions.
• To determine the cellular localization and functional implications of Nrf2 in the context of MS pathology.
• To analyze the differential gene expression of Nrf2-responsive genes in white matter and gray matter MS lesions.

Main Methods:

• Immunohistochemistry to detect Nrf2 and its downstream targets (heme oxygenase 1) in MS lesions.
• Analysis of Nrf2 expression in different cell types, including oligodendrocytes and neurons.
• Whole-genome microarray analysis to identify differentially expressed Nrf2-responsive genes in MS lesions.

Main Results:

• Nrf2 is strongly upregulated in active MS lesions, with prominent nuclear expression in oligodendrocytes.
• Functional Nrf2 activity, indicated by heme oxygenase 1 expression, is observed in oligodendrocytes within MS lesions.
• Nrf2 expression is highest in degenerating cells exhibiting signs of apoptosis or necrosis.
• Differential expression of numerous Nrf2-responsive genes involved in oxidative stress defense occurs in actively demyelinating white matter lesions.
• Distinct expression patterns of Nrf2-induced genes are observed between white matter and cortical gray matter in MS.

Conclusions:

• Nrf2 is significantly upregulated in active MS lesions, particularly in oligodendrocytes, and is associated with active demyelination.
• The Nrf2 pathway is active in oligodendrocytes within MS lesions, suggesting a role in cellular defense against oxidative stress.
• Nrf2 expression patterns and the response of its target genes vary across different cell types and anatomical regions (white vs. gray matter) in the MS brain.